Target intelligence / Profile preview

Glutamate receptor ionotropic, kainate 1 (GluK1)

Target
GluK1
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor
01

Overview

Glutamate receptor ionotropic, kainate 1 (GluK1), encoded by the GRIK1 gene, is a subunit of the ionotropic glutamate receptor family that functions as a ligand-gated ion channel. It mediates fast excitatory neurotransmission in both the central and peripheral nervous systems by allowing the influx of cations (such as sodium and calcium) upon binding to glutamate or kainate. Beyond its canonical ionotropic role, GluK1 is also involved in noncanonical metabotropic signaling through G-protein coupling, which modulates the release of other neurotransmitters like GABA. GluK1 is highly expressed in key brain regions, including the hippocampus, amygdala, and dorsal root ganglia, making it a critical player in synaptic plasticity, sensory processing, and pain transmission. Consequently, GluK1 is a major therapeutic target for neurological and psychiatric disorders, including epilepsy, migraine, chronic pain, and alcohol use disorder. Pharmacological modulation of GluK1, particularly through selective antagonists like tezampanel and LY466195, aims to reduce neuronal hyperexcitability and has shown therapeutic potential in clinical and preclinical models.

Other names
GRIK1GluR5Glutamate receptor 5Excitatory amino acid receptor 3EAA3EEA3GLUR5GLR5Glutamate ionotropic receptor kainate type subunit 1
02

Mechanism of action

Antagonist, Agonist, Allosteric modulator

03

Biological functions

Synaptic transmissionNeurotransmissionIon transmembrane transportSignal transductionMetabotropic signaling
04

Disease associations

EpilepsyPainMigraineAlcohol use disorderSchizophreniaAutismNeurodegenerative disease
05

Safety considerations

Cognitive impairmentSedationParesthesiaMotor coordination issues
06

Interacting drugs

12 more in the full profile.

07

Biomarkers

GRIK1 genetic variantsGRIK1 rs2832407 single nucleotide polymorphismRNA editing (Q/R site)

Beyond the preview

Go deeper on Glutamate receptor ionotropic, kainate 1 (GluK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic, kainate 1 (GluK1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call